AbbVie Revenue 2010-2018 | ABBV

Current and historical revenue for AbbVie (ABBV) from 2010 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for AbbVie as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.564B $28.216B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $346.390B 16.55
Pfizer (PFE) United States $224.125B 13.79
Novartis AG (NVS) Switzerland $182.384B 15.80
Merck (MRK) United States $168.593B 15.07
Novo Nordisk (NVO) Denmark $122.519B 20.30
Sanofi (SNY) France $105.189B 13.31
GlaxoSmithKline (GSK) United Kingdom $102.004B 13.95
Eli Lilly (LLY) United States $97.222B 19.30
AstraZeneca (AZN) United Kingdom $94.148B 9.86
Bristol-Myers Squibb (BMY) United States $92.564B 18.21